News

NEW YORK, NY – TB Alliance, an international non-profit drug development organization that develops better, faster-acting, and affordable tuberculosis (TB)

30 October 2013 (PARIS, FRANCE): In an effort to develop and deliver treatments for children with tuberculosis (TB)—answering a critical

TB Alliance, a not-for-profit organization with the mission of developing better, faster-acting, and affordable TB treatments, announces the election of

As Product Development Partnerships (PDPs) dedicated to the discovery, development and delivery of new global health tools, we applaud the

TB Alliance, an international non-profit organization which develops better, faster-acting, and affordable TB drugs, has announced that it has granted

Over the past year, the pursuit of new TB drugs has seen incredible progress. Positive results of first regimen trial